Biotech ETF Rises 17% in a Month Without NVIDIA
A biotech ETF posts a 17% gain in the trailing month even as NVIDIA weakens, underscoring a sector rotation that chal...
Which Dividend Fund Charges Least Fees
This piece highlights Which Dividend Fund Charges Least Fees and the factors to consider when evaluating expense structures.
23,858 articlesAmazon: Andy Jassy's Historic Move Signals AI Investment Push
A massive debt issuance reveals where Amazon is headed under Andy Jassy. This article breaks down the implications fo...
XPEL (XPEL) 2025 Earnings Outlook: Key Watchpoints
As XPEL gears up for 2025 earnings insights, investors need a clear view of growth drivers, margin discipline, and po...
Prediction: Applied Digital Stock Could Surge If This Happens
As AI demand grows, one data-center play stands out for potential upside. This piece breaks down the catalysts, risks...
U.S. Treasury Pays Billion a Day as Debt Near $39 Trillion
The latest CBO budget update shows the Treasury's interest costs rising to nearly $3 billion per day as debt nears $3...
Billionaire Philippe Laffont Trimmed: Two Big Moves
When a renowned investor rebalances a multibillion-dollar portfolio, the moves ripple through markets. This piece exp...
CRISPR Therapeutics $2.4 Billion Cash: Why the Stock Slump Persists
CRISPR Therapeutics wields a rare card: a cash-rich balance sheet and an approved gene therapy. But the stock refuses...
Homebody Portfolio: How Much Does Retirement Cost Locally
A growing number of retirees are choosing to stay in Chicago, turning a local lifestyle into a cost-saving retirement...
Where Will Lucid Stock Be in Three Years? A Guide
Investors wonder about the path ahead for Lucid stock. This guide lays out three scenarios, the key drivers, and conc...
Dementia Retirement’s Most Expensive Bill Hits Medicare Gap
A dementia diagnosis reshapes retirement plans as custodial care bills far exceed medical costs and Medicare coverage...
This Stock Soared 123%: Is It Still a Buy for 2026?
A fast IPO run can leave investors excited but unsure what comes next. We break down whether this stock soared 123% s...
Assertio (ASRT) 2025 Earnings: What Investors Watch
As Assertio prepares to discuss its Q4 2025 results, investors look for clues about product performance, margins, and...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status